A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphoma
Shi, Yuankai, Song, Yongping, Qin, Yan, Zhang, Qingyuan, Han, Xiaohong, Hong, Xiaonan, Wang, Dong, Li, Wei, Zhang, Yang, Feng, Jifeng, Yang, Jianmin, Zhang, Huilai, Jin, Chuan, Yang, Yu, Hu, Jianda, WVolume:
13
Journal:
Journal of Hematology & Oncology
DOI:
10.1186/s13045-020-00871-9
Date:
December, 2020
File:
PDF, 480 KB
2020